Numira is a specialty preclinical CRO that combines innovative technologies and expertise to provide unique solutions to a wide variety of preclinical drug discovery efforts. We support leading pharmaceutical, biotech, and medical device companies in the areas of discovery research and efficacy evaluation, offering services in the following areas: High-Resolution MicroCT Imaging Image Analysis (microCT, MRI, ECG, histology data) Specialized Histology (GLP or non-GLP) 3D Oncology Cell Screening Utilizing our patented imaging reagents and powerful 3D visualization and analytic tools, we provide images, metrics, and analyses that will allow definitive answers much more rapidly and accurately than ever before, saving your team valuable time and resources. Therapeutic areas include: Inflammation, pulmonary, musculoskeletal, ocular, oncology, cardiovascular, CNS, devices.